CO7350653A2 - Retinoides y uso de los mismos - Google Patents

Retinoides y uso de los mismos

Info

Publication number
CO7350653A2
CO7350653A2 CO15041667A CO15041667A CO7350653A2 CO 7350653 A2 CO7350653 A2 CO 7350653A2 CO 15041667 A CO15041667 A CO 15041667A CO 15041667 A CO15041667 A CO 15041667A CO 7350653 A2 CO7350653 A2 CO 7350653A2
Authority
CO
Colombia
Prior art keywords
retinoids
compounds
neoplastic
disorders
humans
Prior art date
Application number
CO15041667A
Other languages
English (en)
Inventor
Wayne J Brouillette
Donal D Muccio
Venkatram Reddy Atigadda
John M Ruppert
Ruppert Susan M Lobo
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of CO7350653A2 publication Critical patent/CO7350653A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona nuevos compuestosRetinoides y usos de los compuestos en humanos y animales paracondiciones o trastornos dérmicos no neoplásicos o inflamatorios.
CO15041667A 2012-08-24 2015-02-25 Retinoides y uso de los mismos CO7350653A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/594,177 US8475775B1 (en) 2012-08-24 2012-08-24 Retinoids and use thereof

Publications (1)

Publication Number Publication Date
CO7350653A2 true CO7350653A2 (es) 2015-08-10

Family

ID=48671166

Family Applications (1)

Application Number Title Priority Date Filing Date
CO15041667A CO7350653A2 (es) 2012-08-24 2015-02-25 Retinoides y uso de los mismos

Country Status (18)

Country Link
US (3) US8475775B1 (es)
EP (1) EP2887928B1 (es)
JP (1) JP6382817B2 (es)
KR (1) KR20150045450A (es)
CN (1) CN104540502A (es)
AU (1) AU2013306281B2 (es)
BR (1) BR112015003561A8 (es)
CA (1) CA2882330A1 (es)
CL (1) CL2015000434A1 (es)
CO (1) CO7350653A2 (es)
ES (1) ES2670499T3 (es)
HU (1) HUE037075T2 (es)
IL (1) IL236991B (es)
IN (1) IN2015DN01524A (es)
MX (1) MX366050B (es)
NZ (1) NZ704496A (es)
RU (1) RU2687285C2 (es)
WO (1) WO2014031242A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10328040B2 (en) 2014-01-17 2019-06-25 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic methods
WO2015130973A1 (en) 2014-02-26 2015-09-03 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US10112917B2 (en) 2015-03-03 2018-10-30 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US10238655B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Dihydroindene and tetrahydronaphthalene compounds
US10238626B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US10231947B2 (en) 2017-01-23 2019-03-19 Arizona Board Of Regents On Behalf Of Arizona State University Isochroman compounds and methods of use thereof
US11696897B2 (en) * 2019-10-02 2023-07-11 Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts, Universitatsmedizin Method for the treatment of diseases associated with sulfatase deficiencies
JP2022056688A (ja) * 2020-09-30 2022-04-11 キオクシア株式会社 半導体装置
CN113207799B (zh) * 2021-03-19 2022-03-15 中山大学 一种二型糖尿病小鼠快速心衰模型的构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5094783A (en) * 1990-06-29 1992-03-10 Uab Research Foundation Retinoid compounds
DE69942505D1 (de) * 1998-04-06 2010-07-29 Uab Research Foundation Neuartige retinoide und deren verwendung
EP1585723A2 (en) * 2003-01-17 2005-10-19 Wisconsin Alumni Research Foundation Modified retinoid compounds and their uses
JP2008510822A (ja) 2004-08-24 2008-04-10 ザ ユーエービー リサーチ ファウンデーション レチノイドを製造する方法およびその使用
EP2389357A4 (en) * 2009-01-20 2013-01-23 Signum Biosciences Inc INFLAMMATORY COMPLEXES
WO2011141822A2 (en) * 2010-05-11 2011-11-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors

Also Published As

Publication number Publication date
WO2014031242A1 (en) 2014-02-27
RU2687285C2 (ru) 2019-05-13
JP2015526464A (ja) 2015-09-10
MX2015002340A (es) 2015-08-05
ES2670499T3 (es) 2018-05-30
EP2887928A4 (en) 2016-03-23
CN104540502A (zh) 2015-04-22
US20140057982A1 (en) 2014-02-27
RU2015103469A (ru) 2016-10-20
EP2887928B1 (en) 2018-02-21
KR20150045450A (ko) 2015-04-28
EP2887928A1 (en) 2015-07-01
BR112015003561A8 (pt) 2018-01-23
IN2015DN01524A (es) 2015-07-03
MX366050B (es) 2019-06-26
BR112015003561A2 (pt) 2017-07-04
HUE037075T2 (hu) 2018-08-28
US20150202174A1 (en) 2015-07-23
CA2882330A1 (en) 2014-02-27
JP6382817B2 (ja) 2018-08-29
IL236991B (en) 2019-03-31
CL2015000434A1 (es) 2015-07-17
AU2013306281B2 (en) 2018-08-02
AU2013306281A1 (en) 2015-02-26
US8475775B1 (en) 2013-07-02
NZ704496A (en) 2017-01-27

Similar Documents

Publication Publication Date Title
CO7350653A2 (es) Retinoides y uso de los mismos
CR20150462A (es) Inhibidores de erk y sus usos
UY34876A (es) Anticuerpos anti-egfr y usos de los mismos
DOP2015000219A (es) Compuestos de heteroarilo y sus usos
CL2015002501A1 (es) Compuestos y usos de estos para la modulación de la hemoglobina
DOP2016000109A (es) Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas.
CR20140529A (es) Anticuerpos e inmunoconjugados contra ly6e y métodos de uso
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
DK2961410T3 (da) Anvendelse af pyrazolopyrimidinderivater til behandlingen af pi3k relaterede lidelser
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34538A (es) Heteroarilos y usos de los mismos
UY34220A (es) Indazoles, composiciones farmacéuticas y uso de los mismos
CL2015000408A1 (es) Compuestos derivados de pirazolo[4,3-d]pirimidina y sus sales; composicion farmaceutica que los comprende, util para el tratamiento de enfermedades alergicas, inflamatorias, infecciosas o cancer.
AR094502A1 (es) Pirazoles sustituidos en posicion 3 y usos de los mismos
UY34271A (es) Anticuerpos anti-tie2 y usos de los mismos
UY34636A (es) Composiciones tópicas que comprenden fipronilo y permetrina y sus métodos de uso
UY34603A (es) Anticuerpos anti-asic-1 y usos de los mismos
BR112014016389A8 (pt) composições e uso das mesmas para o tratamento de distúrbios e doenças hepáticas
ECSP16008797A (es) Derivados de heterobicicloaril como inhibidores rorc2 y métodos de uso de los mismos
BR112015002706A2 (pt) niclosamida e seus derivados para uso no tratamento de tumores sólidos
UY34018A (es) Derivados glucósidos y usos de los mismos
CU24407B1 (es) Moduladores de pirrolopiridina de rorc2 sustituidos con metilo y trifluorometilo
UY34616A (es) Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias.
CL2015001530A1 (es) Uso de inhibidores de telomerasa para el tratamiento de desórdenes mieloproliferativos y neoplasias mieloproliferativas